Journal of Lipid Nutrition

Show abstractHide abstract

N-3 polyunsaturated fatty acids (n-3 PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic aids (DHA), are abundant in fish oil, have received increasing attention in various clinical fields. The action of n-3 PUFAs is performed as components of cell membranes or through the production of eicosanoids and docosanoids, including prostaglandins (PGs) and leukotriens (LTs). In pediatric practice, n-3 PUFAs participate in the development of visual and brain functions in infants and in the anti-inflammatory and anti-allergic functions. This paper reports the results of our clinical and animal studies concerning the effects of n-3 PUFAs on inflammatory bowel disease (IBD), allergic diseases, and development of children. Our data clearly demonstrates that n-3 PUFAs, including DHA and EPA, are effective in the treatment of IBD and allergic diseases and are involved in the development of children and even mature infants.

View full abstract

Download PDF (616K)

Register with J-STAGE for free!